Rezolute, Inc.
NASDAQ:RZLT · NASDAQ Capital Market
+$0.30 today
Vol 2.81M · Avg 2.03M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+24.57%
Period High
$10.94
Period Low
$1.40
Latest
$5.02
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Nanobiotix S.A.
NASDAQ:NBTX
$1.81B
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.67B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.12B
Savara Inc.
NASDAQ:SVRA
$1.12B
Kura Oncology, Inc.
NASDAQ:KURA
$858.89M
Geron Corporation
NASDAQ:GERN
$830.71M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$746.52M
Prime Medicine, Inc.
NASDAQ:PRME
$564.43M
ProKidney Corp.
NASDAQ:PROK
$260.21M
What is the latest RZLT filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does RZLT have?
Intrinsic Alpha currently shows 20 recent filings for RZLT.
Explore More
Continue the stock analysis
Jump to another research area for this company.